Accounts Receivable, after Allowance for Credit Loss, Current of Organon & Co. from 31 Dec 2020 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
Organon & Co. quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD history and change rate from 31 Dec 2020 to 31 Dec 2025.
  • Organon & Co. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending 31 Dec 2025 was $1,331,000,000, a 2% decline year-over-year.
Source SEC data
View on sec.gov
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Change (%)

Organon & Co. Quarterly Accounts Receivable, after Allowance for Credit Loss, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $1,331,000,000 -$27,000,000 -2% 31 Dec 2025 10-K 24 Feb 2026 2025 FY
Q3 2025 $1,484,000,000 -$201,000,000 -12% 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 $1,484,000,000 -$133,000,000 -8.2% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $1,457,000,000 -$90,000,000 -5.8% 31 Mar 2025 10-Q 02 May 2025 2025 Q1
Q4 2024 $1,358,000,000 -$386,000,000 -22% 31 Dec 2024 10-K 24 Feb 2026 2025 FY
Q3 2024 $1,685,000,000 +$37,000,000 +2.2% 30 Sep 2024 10-Q 01 Nov 2024 2024 Q3
Q2 2024 $1,617,000,000 -$55,000,000 -3.3% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 $1,547,000,000 +$102,000,000 +7.1% 31 Mar 2024 10-Q 03 May 2024 2024 Q1
Q4 2023 $1,744,000,000 +$269,000,000 +18% 31 Dec 2023 10-K/A 10 Nov 2025 2024 FY
Q3 2023 $1,648,000,000 +$208,000,000 +14% 30 Sep 2023 10-Q 03 Nov 2023 2023 Q3
Q2 2023 $1,672,000,000 +$182,000,000 +12% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $1,445,000,000 +$123,000,000 +9.3% 31 Mar 2023 10-Q 05 May 2023 2023 Q1
Q4 2022 $1,475,000,000 +$93,000,000 +6.7% 31 Dec 2022 10-K 26 Feb 2024 2023 FY
Q3 2022 $1,440,000,000 -$58,000,000 -3.9% 30 Sep 2022 10-Q 04 Nov 2022 2022 Q3
Q2 2022 $1,490,000,000 -$17,000,000 -1.1% 30 Jun 2022 10-Q 05 Aug 2022 2022 Q2
Q1 2022 $1,322,000,000 +$312,000,000 +31% 31 Mar 2022 10-Q 06 May 2022 2022 Q1
Q4 2021 $1,382,000,000 +$344,000,000 +33% 31 Dec 2021 10-K 27 Feb 2023 2022 FY
Q3 2021 $1,498,000,000 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 $1,507,000,000 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 $1,010,000,000 31 Mar 2021 10-Q 21 Jun 2021 2021 Q1
Q4 2020 $1,038,000,000 31 Dec 2020 10-K 21 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.